MedTrace Logo

Validating the 'Sexual Minorities and Prostate Cancer Scale' to Gold Standard Questionnaires

NCT05772598 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 305

Last updated 2024-04-03

No results posted yet for this study

Summary

A cohort study comparing the novel 'Sexual Minorities and Prostate Cancer Scale' (SMACS) to the gold standard questionnaires investigating erectile dysfunction (IIEF) and incontinence (ICIQLUTSqol and ICIQ-UI) following robotic assisted radical prostatectomy

Conditions

  • Prostate Cancer
  • Incontinence
  • Erectile Dysfunction Following Radical Prostatectomy

Sponsors & Collaborators

  • Guy's and St Thomas' NHS Foundation Trust

    lead OTHER

Eligibility

Min Age
40 Years
Max Age
75 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-03-15
Primary Completion
2023-08-02
Completion
2023-08-02

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05772598 on ClinicalTrials.gov